BRPI0810475A2 - uso de dimiracetam no tratamento de dor crônica - Google Patents

uso de dimiracetam no tratamento de dor crônica

Info

Publication number: BRPI0810475A2
Authority: BR; Brazil
Prior art keywords: dimiracetam; treatment; chronic pain; pain; chronic
Prior art date: 2007-04-16

Application number

BRPI0810475A

Other languages

English (en)

Inventor

Carla Ghelardini

Carlo Farina

Paola Petrillo

Original Assignee

Neurotune Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-16

Filing date

2008-04-15

Publication date

2015-10-20

2008-04-15 Application filed by Neurotune Ag filed Critical Neurotune Ag

2015-10-20 Publication of BRPI0810475A2 publication Critical patent/BRPI0810475A2/pt

Links

208000000094 Chronic Pain Diseases 0.000 title 1
208000002193 Pain Diseases 0.000 title 1
XTXXOHPHLNROBN-UHFFFAOYSA-N dimiracetam Chemical compound N1C(=O)CN2C1CCC2=O XTXXOHPHLNROBN-UHFFFAOYSA-N 0.000 title 1
229950002911 dimiracetam Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0810475A 2007-04-16 2008-04-15 uso de dimiracetam no tratamento de dor crônica BRPI0810475A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000770A ITMI20070770A1 (it)	2007-04-16	2007-04-16	Impiego di dimiracetam nel trattamento del dolore cronico
PCT/EP2008/054553 WO2008125674A1 (en)	2007-04-16	2008-04-15	Use of dimiracetam in the treatment of chronic pain

Publications (1)

Publication Number	Publication Date
BRPI0810475A2 true BRPI0810475A2 (pt)	2015-10-20

Family

ID=39628738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810475A BRPI0810475A2 (pt)	2007-04-16	2008-04-15	uso de dimiracetam no tratamento de dor crônica

Country Status (15)

Country	Link
US (2)	US7989421B2 (pt)
EP (3)	EP2620149A3 (pt)
JP (1)	JP5409602B2 (pt)
CN (2)	CN101677984A (pt)
AU (1)	AU2008237901B2 (pt)
BR (1)	BRPI0810475A2 (pt)
CA (1)	CA2684363C (pt)
EA (2)	EA019354B1 (pt)
ES (2)	ES2584161T3 (pt)
IL (2)	IL201498A (pt)
IT (1)	ITMI20070770A1 (pt)
MX (1)	MX2009011380A (pt)
PL (2)	PL2857017T3 (pt)
WO (1)	WO2008125674A1 (pt)
ZA (1)	ZA200906991B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9125898B2 (en)	2008-11-14	2015-09-08	Neurotune Ag	Acetam derivatives for pain relief
US8476453B2 (en)	2010-07-26	2013-07-02	Neurotune Ag	Process for the preparation of dimiracetam
CA2828238A1 (en) *	2010-10-29	2012-05-03	Neurotune Ag	Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
JPWO2012137645A1 (ja) *	2011-04-07	2014-07-28	旭化成ファーマ株式会社	抗癌剤に起因する異痛症の予防及び／又は治療剤
CN102743372B (zh) *	2012-06-30	2015-09-09	江苏省中医药研究院	一种化疗致血痹动物模型建立方法
JOP20190251A1 (ar) *	2017-05-31	2019-10-21	Metys Pharmaceuticals AG	تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
US20200361973A1 (en) *	2017-11-21	2020-11-19	Medoncare Pharmaceutical Co., Ltd.	Combination product comprising dicycloplatin and preparation method and use thereof
DE102019107619A1 (de)	2019-03-25	2020-10-01	Mondi Ag	Verpackungsbeutel aus einem Kunststoffgewebeverbund
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3324219A1 (de) *	1983-07-05	1985-01-17	Hoechst Ag, 6230 Frankfurt	Mehrlagige elektroisolierfolie
US5028595A (en) *	1987-09-18	1991-07-02	Hoffmann-La Roche Inc.	Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
IT1233860B (it)	1988-02-08	1992-04-21	Isf Spa	Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
GB9123641D0 (en)	1991-11-07	1992-01-02	Isf Spa	Process
RO121085B1 (ro) *	1999-12-01	2006-12-29	Ucb, S.A.,	Utilizarea levetiracetamului, în tratamentul bolilor sistemului nervos central
CN1484527A (zh) *	2000-12-28	2004-03-24	��һ��ҩ��ʽ��	神经性疼痛治疗和预防药
ITMI20030573A1 (it) *	2003-03-24	2004-09-25	Nikem Research Srl	Composti ad azione nootropica, loro preparazione,

2007
- 2007-04-16 IT IT000770A patent/ITMI20070770A1/it unknown
2008
- 2008-04-15 EP EP13002151.2A patent/EP2620149A3/en not_active Withdrawn
- 2008-04-15 PL PL14004202.9T patent/PL2857017T3/pl unknown
- 2008-04-15 WO PCT/EP2008/054553 patent/WO2008125674A1/en not_active Ceased
- 2008-04-15 CN CN200880015837A patent/CN101677984A/zh active Pending
- 2008-04-15 AU AU2008237901A patent/AU2008237901B2/en not_active Ceased
- 2008-04-15 BR BRPI0810475A patent/BRPI0810475A2/pt not_active IP Right Cessation
- 2008-04-15 PL PL08749565T patent/PL2146706T3/pl unknown
- 2008-04-15 EP EP08749565.1A patent/EP2146706B1/en active Active
- 2008-04-15 US US12/450,944 patent/US7989421B2/en active Active
- 2008-04-15 CN CN201310182360.3A patent/CN103284997B/zh not_active Expired - Fee Related
- 2008-04-15 EP EP14004202.9A patent/EP2857017B1/en active Active
- 2008-04-15 ES ES14004202.9T patent/ES2584161T3/es active Active
- 2008-04-15 MX MX2009011380A patent/MX2009011380A/es active IP Right Grant
- 2008-04-15 EA EA200901237A patent/EA019354B1/ru not_active IP Right Cessation
- 2008-04-15 EA EA201300826A patent/EA022867B1/ru not_active IP Right Cessation
- 2008-04-15 ES ES08749565.1T patent/ES2536631T3/es active Active
- 2008-04-15 CA CA2684363A patent/CA2684363C/en not_active Expired - Fee Related
- 2008-04-15 JP JP2010503482A patent/JP5409602B2/ja active Active
2009
- 2009-10-07 ZA ZA2009/06991A patent/ZA200906991B/en unknown
- 2009-10-13 IL IL201498A patent/IL201498A/en active IP Right Grant
2011
- 2011-06-22 US US13/166,088 patent/US8222241B2/en active Active
2012
- 2012-03-26 IL IL218851A patent/IL218851A/en active IP Right Grant

Also Published As

Publication number	Publication date
ZA200906991B (en)	2011-03-30
IL201498A0 (en)	2010-05-31
US20110251250A1 (en)	2011-10-13
ES2536631T3 (es)	2015-05-27
JP2010524882A (ja)	2010-07-22
US7989421B2 (en)	2011-08-02
EA019354B1 (ru)	2014-03-31
IL218851A (en)	2013-09-30
EP2620149A3 (en)	2013-08-07
CA2684363C (en)	2016-02-09
CN103284997A (zh)	2013-09-11
US20100129469A1 (en)	2010-05-27
MX2009011380A (es)	2010-07-06
EA022867B1 (ru)	2016-03-31
ES2584161T3 (es)	2016-09-26
WO2008125674A1 (en)	2008-10-23
PL2146706T3 (pl)	2015-07-31
CN103284997B (zh)	2015-06-03
EP2146706A1 (en)	2010-01-27
PL2857017T3 (pl)	2016-11-30
EP2146706B1 (en)	2015-02-25
HK1209053A1 (en)	2016-03-24
ITMI20070770A1 (it)	2008-10-17
CN101677984A (zh)	2010-03-24
JP5409602B2 (ja)	2014-02-05
EP2857017A3 (en)	2015-05-06
EA200901237A1 (ru)	2010-04-30
AU2008237901A1 (en)	2008-10-23
US8222241B2 (en)	2012-07-17
EP2620149A2 (en)	2013-07-31
IL201498A (en)	2013-10-31
CA2684363A1 (en)	2008-10-23
EP2857017A2 (en)	2015-04-08
EA201300826A1 (ru)	2013-11-29
IL218851A0 (en)	2012-05-31
EP2857017B1 (en)	2016-05-25
AU2008237901B2 (en)	2013-06-27

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-04-16	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-05-07	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-08-20	B09B	Patent application refused [chapter 9.2 patent gazette]
2019-11-12	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2023-02-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 15A ANUIDADE.
2023-05-23	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2718 DE 07-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
CY2020043I1 (el)	2021-03-12	Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας
PL2037902T3 (pl)	2013-12-31	Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
BRPI0907135A2 (pt)	2015-07-14	Processos de tratamento de dor crônica
BRPI0920216A2 (pt)	2019-09-24	forma de dosagem intraoral em múltiplas porções e uso das mesmas
PT2252283T (pt)	2019-01-23	Triterpenóides sintéticos e métodos de uso no tratamento de doença
PL2468290T3 (pl)	2015-08-31	Antagoniści aktywiny-ActRII do stosowania w leczeniu niedokrwistości
SI3424932T1 (sl)	2021-08-31	Boronoftalidi za terapevtsko uporabo
HUE038588T2 (hu)	2018-10-29	IL-22 mikrobiális rendellenességek kezelésében történõ alkalmazásra
IL211328A0 (en)	2011-04-28	Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
GB0719803D0 (en)	2007-11-21	Therapeutic compounds and their use
BRPI0813955A2 (pt)	2017-05-09	composições terapêuticas e o uso das mesmas
GB0719644D0 (en)	2007-11-14	Therapeutic compounds and their use
BRPI0820477A2 (pt)	2015-06-16	Compostos de benzodiazepinona úteis no tratamento de afecções da pele
BRPI0719345A2 (pt)	2014-03-18	Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
BRPI0818766A2 (pt)	2015-04-14	N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
PL1912650T3 (pl)	2018-01-31	Zastosowanie flibanseryny w leczeniu otyłości
IL218851A0 (en)	2012-05-31	Use of dimiracetam in the treatment of chronic pain
EP3381471C0 (en)	2024-03-20	PAIN TREATMENT
DK1863899T3 (da)	2013-10-14	Hudbehandlingspræparater
BRPI0720323A2 (pt)	2016-08-09	composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0817483A2 (pt)	2016-07-26	uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor
BRPI0714318A2 (pt)	2014-06-24	Utilização de 2-benzoil-imidazopiridinas em terapêutica
GB0822486D0 (en)	2009-01-14	Compounds for use in the treatment of pain
BRPI0821026A2 (pt)	2015-06-16	Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
BRPI0909096A2 (pt)	2015-12-01	uso de conjugados de interleicna-1 no tratamento de diabetes